1029 related articles for article (PubMed ID: 35577046)
1. Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment.
Huang X; Mu N; Ding Y; Lam HW; Yue L; Gao C; Chen T; Yuan Z; Wang R
Acta Biomater; 2022 Jul; 147():356-365. PubMed ID: 35577046
[TBL] [Abstract][Full Text] [Related]
2. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-based supramolecular nanomedicine with optimized ratio of oxaliplatin/chlorin e6 for combined chemotherapy and O
Ding YF; Xu X; Li J; Wang Z; Luo J; Mok GSP; Li S; Wang R
Acta Biomater; 2023 Jul; 164():397-406. PubMed ID: 37004784
[TBL] [Abstract][Full Text] [Related]
4. Enzyme and Reactive Oxygen Species-Responsive Dual-Drug Delivery Nanocomplex for Tumor Chemo-Photodynamic Therapy.
Xie Q; Gao S; Tian R; Wang G; Qin Z; Chen M; Zhang W; Wen Q; Ma Q; Zhu L
Int J Nanomedicine; 2023; 18():1-16. PubMed ID: 36632237
[TBL] [Abstract][Full Text] [Related]
5. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
7. A nanomedicine composed of polymer-ss-DOX and polymer-Ce6 prodrugs with monoclonal antibody targeting effect for anti-tumor chemo-photodynamic synergetic therapy.
Yu L; Zhang M; He J; Sun X; Ni P
Acta Biomater; 2024 Apr; 179():272-283. PubMed ID: 38460931
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional theranostic agents based on prussian blue nanoparticles for tumor targeted and MRI-guided photodynamic/photothermal combined treatment.
Lin X; Cao Y; Xue Y; Wu F; Yu F; Wu M; Zhu X
Nanotechnology; 2020 Mar; 31(13):135101. PubMed ID: 31783383
[TBL] [Abstract][Full Text] [Related]
9. pH-responsive and self-targeting assembly from hyaluronic acid-based conjugate toward all-in-one chemo-photodynamic therapy.
Wu J; Hu X; Liu R; Zhang J; Song A; Luan Y
J Colloid Interface Sci; 2019 Jul; 547():30-39. PubMed ID: 30933691
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable nanocomplex from hyaluronic acid and arginine based poly(ester amide)s as the delivery vehicles for improved photodynamic therapy of multidrug resistant tumor cells: An in vitro study of the performance of chlorin e6 photosensitizer.
Ji Y; Zhao J; Chu CC
J Biomed Mater Res A; 2017 May; 105(5):1487-1499. PubMed ID: 27997760
[TBL] [Abstract][Full Text] [Related]
11. Peptide 18-4/chlorin e6-conjugated polyhedral oligomeric silsesquioxane nanoparticles for targeted photodynamic therapy of breast cancer.
Kim YJ; Lee HI; Kim JK; Kim CH; Kim YJ
Colloids Surf B Biointerfaces; 2020 May; 189():110829. PubMed ID: 32036332
[TBL] [Abstract][Full Text] [Related]
12. Amphiphilic block polymer-based self-assembly of high payload nanoparticles for efficient combinatorial chemo-photodynamic therapy.
Ma Q; Zhao Y; Guan Q; Zhao Y; Zhang H; Ding Z; Wang Q; Wu Y; Liu M; Han J
Drug Deliv; 2020 Nov; 27(1):1656-1666. PubMed ID: 33233958
[TBL] [Abstract][Full Text] [Related]
13. Novel carrier-free nanoparticles composed of 7-ethyl-10-hydroxycamptothecin and chlorin e6: Self-assembly mechanism investigation and in vitro/in vivo evaluation.
Zhao Y; Zhao Y; Ma Q; Zhang H; Liu Y; Hong J; Ding Z; Liu M; Han J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110722. PubMed ID: 31887649
[TBL] [Abstract][Full Text] [Related]
14. Nanodrug-loaded Bifidobacterium bifidum conjugated with anti-death receptor antibody for tumor-targeted photodynamic and sonodynamic synergistic therapy.
Li W; Zhang Z; Liu J; Wang B; Pu G; Li J; Huang Y; Chu M
Acta Biomater; 2022 Jul; 146():341-356. PubMed ID: 35580829
[TBL] [Abstract][Full Text] [Related]
15. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
[TBL] [Abstract][Full Text] [Related]
16. Targeted chemo-photodynamic therapy toward esophageal cancer by GSH-sensitive theranostic nanoplatform.
Ren G; Wang Z; Tian Y; Li J; Ma Y; Zhou L; Zhang C; Guo L; Diao H; Li L; Lu L; Ma S; Wu Z; Yan L; Liu W
Biomed Pharmacother; 2022 Sep; 153():113506. PubMed ID: 36076595
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment triple-responsive nanoparticles enable enhanced tumor penetration and synergetic chemo-photodynamic therapy.
Shu M; Tang J; Chen L; Zeng Q; Li C; Xiao S; Jiang Z; Liu J
Biomaterials; 2021 Jan; 268():120574. PubMed ID: 33271451
[TBL] [Abstract][Full Text] [Related]
18. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy.
Zhang P; Wu Q; Yang J; Hou M; Zheng B; Xu J; Chai Y; Xiong L; Zhang C
Acta Biomater; 2022 Jul; 146():450-464. PubMed ID: 35526739
[TBL] [Abstract][Full Text] [Related]
20. Calcium carbonate nanoparticles tumor delivery for combined chemo-photodynamic therapy: Comparison of local and systemic administration.
Yakubova AA; Mitusova KA; Darwish A; Rogova A; Ageev EI; Brodskaia A; Muslimov AR; Zyuzin MV; Timin AS
J Control Release; 2023 Jul; 359():400-414. PubMed ID: 37315692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
